Navigation Links
Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
Date:10/24/2007

SAN MATEO, Calif., Oct. 24 /PRNewswire/ -- Anthera Pharmaceuticals, Inc., a privately-held biopharmaceutical company, reported results of a Phase II clinical trial of its first compound, A-002, for the treatment of cardiovascular disease. The trial results suggest that treatment with A-002 resulted in significant reductions in blood levels of total cholesterol, Non- High Density Lipoprotein Cholesterol (non HDL-C), and Low Density Lipoprotein Cholesterol (LDL-C), known as "bad" cholesterol, coupled with equally meaningful reductions of C-Reactive Protein (CRP), a recognized marker of inflammation and cardiovascular risk. Decreases in these levels with A-002 treatment were most significant among patients already on a background of statin therapy.

The Phase II PLASMA trial (Phospholipase Levels And Serological Markers of Atherosclerosis) was a multi-center, randomized, double-blind, placebo- controlled trial that enrolled approximately 400 patients with stable coronary heart disease in the U.S. and Ukraine. Subjects were randomized to receive one of four different doses of A-002 or placebo for up to eight weeks. Patients also received doctor-determined standard of care therapies. The primary endpoint, a reduction in secretory phospholipase A2 (sPLA2) levels was achieved with a high degree of statistical significance. In addition, the results also demonstrated clinically meaningful as well as statistically significant decreases in cholesterol levels (LDL-C, non-HDL and total cholesterol) in patients with stable coronary heart disease. Clinically meaningful decreases in inflammation, as measured by levels of CRP, were also observed in the relevant patient population. Full data will be presented in a scientific journal during 2008.

"The results of the PLASMA trial support our belief that A-002's unique mechanism of action has a dual effect on lipids and inflammation, which could provide significant therapeutic benefit to patients currently on backgroun
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 Today, the ... (NABP ® ) issued a report urging greater ... action is taken against websites illegally selling medications ... Drug Outlet Identification Program Progress Report for State ... thousands of websites illegally distribute medications and ...
(Date:7/31/2015)... BOSTON , July 31, 2015  Boston ... children benefiting from 3D printing of their anatomy ... had life-threatening cerebrovascular malformations (abnormalities in the brain,s ... Reporting online today in the Journal ... use of 3D printing and synthetic resins to ...
(Date:7/31/2015)... 2015 Quietly, sedately, Morocco,s pharmaceutical ... domestic pharmaceutical industry is strong, with a well-developed base ... international standards. One place where the quality ... Africa: Morocco has quietly become the second largest African ... . Indeed, Moroccan pharma companies have been making ...
Breaking Medicine Technology:NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 33D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3
... BEND, Ore. and NOTTINGHAM, England, Nov. 10, 2010 ... leading independent drug-formulation development and manufacturing company, and ... ("Quotient," www.quotientbioresearch.com ), a leading developer of ... collaboration that can speed the advance of compounds ...
... Group (MRG), the global authority on medical technology market ... multiple geographies, including the US, Canada, Europe, Japan, Brazil, ... specific devices such as internal fixation devices, including plates ... as external fixation devices. They also provide a detailed ...
Cached Medicine Technology:Quotient Clinical and Bend Research Announce Collaboration to Accelerate Advancement of New Medicines 2Quotient Clinical and Bend Research Announce Collaboration to Accelerate Advancement of New Medicines 3New Trauma Market Research Data Covering Multiple Geographies Released by Millennium Research Group 2
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, Sigma Theta Tau ... of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. Key nurse leaders ... Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit of Human Resources ...
(Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... festival will end on Sunday, August 2nd. , Music fans have traveled ... unique and unbelievably popular festival attracts the best in entertainment from around the world. ...
(Date:7/31/2015)... ... 2015 , ... Recently touted by Becker’s Healthcare as one ... , Jvion continues to disrupt the predictive analytic and big data market using ... population level illness to drive prevention and better health outcomes. Most recently, Jvion ...
(Date:7/31/2015)... Tenn. (PRWEB) , ... July 31, 2015 , ... The ... Robert Church Park in Downtown Memphis on October 3, 2015. The Ride to Fight ... focused on cancer research between Methodist Healthcare, The West Clinic and The University of ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... There’s no ... possible, even when it comes time to cook the next meal, making July the ... July by practicing best grilling tips and recipes. , Make the next cookout different ...
Breaking Medicine News(10 mins):Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3
... -- Americans who were jobless for longer than 25 weeks ... those who were continuously employed to suffer mental health issues ... Being jobless also has a greater psychological impact on people ... with less education, the researchers found. The study involved ...
... help people with Parkinson,s disease improve their gait and balance, ... School of Nursing and Red Hill Studios, a California serious ... three-month research project showed small improvements in walking speed, balance ... the first research team in the United States to receive ...
... (Oct. 19, 2011) -- A review of the genetic ... link between the widely diagnosed neurological disorder and Type ... recent decades. "It appears that both Type 2 ... impaired glucose tolerance and hyperinsulinemia," said Rice University biochemist ...
... -- Men who get moderate amounts of exercise have better ... active, a new study finds. Motility refers to the ... important factor in fertility. The study by researchers at ... samples and information about their physical activity levels. The men ...
... solutions to dangerous water quality issues in refugee camps is ... High Commissioner for Refugees an agreement that will put ... lab and on the ground in Kenya, Uganda, Liberia and ... additional SMU funds, faculty member Andrew Quicksall and his graduate ...
... Society (ACS), the American Society for Colposcopy and Cervical ... (ASCP) have proposed new guidelines for the prevention and ... are now posted for public comment, generally advise that ... their lifetime to better ensure that they receive the ...
Cached Medicine News:Health News:Long-Term Unemployment Can Tax Mental Health 2Health News:Computer games help people with Parkinson's disease 2Health News:Research proposes common link between autism, diabetes 2Health News:Research proposes common link between autism, diabetes 3Health News:Sperm Moves Best for Moderate Exercisers: Study 2Health News:SMU scientists to lead water quality study at UN refugee camps 2Health News:SMU scientists to lead water quality study at UN refugee camps 3Health News:Health groups issue proposed cervical cancer screening guidelines 2Health News:Health groups issue proposed cervical cancer screening guidelines 3
... Quick & Easy Adjustment Of Blade Separation ... And Patient Comfort (Unlike Spring Action Speculum ... The Blades. No Laborious, Tedious, Slow Screw ... , ,Available In Either Solid Blade Or ...
... Hourglass Jaw Design Holds The Lens ... Incision.,Mirror Polished Blades Keep The Optic ... Offers Control Over Release Of The ... From Tilting During Insertion.,Reusable, Autoclaveable, Made ...
... The 0.1mm Pierce Tip Opening ... Flap, Without The Need For A Separate Cystotome. ... Grasping Positions Without Elevating The Incision.,The Distal Jaws ... Blades Help To Prevent Inadvertent Pick Up Of ...
2.5V Halogen source, fiber-optic delivery, 3X magnification, pocket-sized....
Medicine Products: